Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Recruiting1
Terminated2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05449548Not ApplicableRecruiting
Lenalidomide in the Treatment of Mucosal Behçet's Syndrome
Oral Ulcer
PrincipalinvestigatorStart date: 2023-04-01
NCT04218565Phase 2Terminated
Golimumab for the Treatment of Refractory Behcet's Uveitis
Behcet SyndromeUveitis
PrincipalinvestigatorStart date: 2020-02-15
NCT03554161Phase 2Terminated
Tocilizumab for the Treatment of Refractory Behcet's Uveitis
Behcet SyndromeUveitis
PrincipalinvestigatorStart date: 2018-05-10

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Rheumatology, Peking Union Medical College Hospital

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05449548Not ApplicablePrincipalInvestigator

Lenalidomide in the Treatment of Mucosal Behçet's Syndrome

Oral Ulcer
Recruiting
NCT04218565Phase 2PrincipalInvestigator

Golimumab for the Treatment of Refractory Behcet's Uveitis

Behcet SyndromeUveitis
Terminated
NCT03554161Phase 2PrincipalInvestigator

Tocilizumab for the Treatment of Refractory Behcet's Uveitis

Behcet SyndromeUveitis
Terminated

All 3 trials loaded